Randox offers kits for therapeutic drug monitoring

Randox Therapeutic Drug Monitoring kits offer accurate determination of drugs in a patient's blood, ensuring that they receive the most effective dosage of medication with the least possible toxicity.

News from Laboratorytalk, 23 February 2010

Randox offers true third-party quality controls

Randox Laboratories has announced that it produces true third-party quality control serum to guarantee independent performance assessment for diagnostic devices, methods and reagents.

News from Laboratorytalk, 20 January 2010

Assay measures amount of aldolase in the blood

Randox has expanded its assay portfolio with the launch of an accurate aldolase test aimed at diagnosing patients that have muscle or liver damage.

News from Laboratorytalk, 27 October 2009

Multistat offers eight cardiac results in minutes

Randox Laboratories has launched the Evidence Multistat - a desktop biochip analyser that offers up to eight cardiac results within 20 minutes.

News from Laboratorytalk, 8 October 2009

Randox kit measures total antioxidant status

Randox has added a total antioxidant status (TAS) kit to its range of antioxidant products to offer a complete profile of patient antioxidant status.

News from Laboratorytalk, 22 September 2009

Advanced liquid CO2 assay for RX analysers

Randox has announced an improvement in liquid CO2 measurement, with enhanced reagent stability for on-board use, calibration and shelf-life on the RX series clinical chemistry analysers.

News from Laboratorytalk, 30 July 2009

Riqas simplifies external quality assessment

Riqas is a large global external quality assessment (EQA) scheme offering 15 comprehensive programmes.

News from Laboratorytalk, 1 July 2009

Biochips ease postmortem blood screening

Randox has developed biochip array technology, based on ELISA principles, for multi-analyte screening.

News from Laboratorytalk, 27 April 2009

Ranbut assay accurately diagnoses ketosis

Randox has introduced the Ranbut assay, which offers high linearity and excellent sensitivity for detecting ketosis in humans and animals.

News from Laboratorytalk, 15 April 2009

Randox Cardiac Array detects MI in six hours

Randox has developed a multi-marker cardiac biochip array for rapid diagnosis of myocardial infarction (MI) and identification of at-risk acute coronary syndrome (ACS) patients.

News from Laboratorytalk, 30 March 2009

• Invest NI gives Randox Innovator of the Year Award

• Randox offers RX analysers for veterinary testing

• Randox presents renal function profile

• Accurate thyroid function testing from Randox

• RanplexCRC able to detect bowel cancer

• Improve analytical quality with global EQA scheme

• Battle sports doping with drug residue Elisas

• Largest EQA scheme in the world expands

• Antioxidant status gives a snapshot of a patient

• High sensitivity, multi-analyte cytokine assays

• Simultaneous testing for thyroid hormones

• Randox wins business of the year award 2008

• Drug residues in your honey?

• Evidence MultiStat speeds up patient diagnosis

• Seventeen synthetic steroids in a single sample

• Keep diabetes in check with Randox HbA1c

• Assessing stress levels with the Cytokine biochip

• Biochip screening test detects growth promoters

• Complete range of diabetes tests from Randox

• Biochip makes early detection of heart attack

• Bile acids test for obstetric cholestasis

• Unravelling cerebrovascular disease

• Complete package for assay development is online

• Biochip detects all fertility hormones

• Non-invasive early detection of colorectal cancer

• Multi-analyte adhesion molecule testing

• RX series makes life easier in the veterinary lab

• Biochips can save lives in MI patients

• Quantitative detection of sd LDL cholesterol

• Don't compromise on quality controls, customise

• Biochip array tests multiple analytes at once

• Randox wins award for international activities

• 25 years of service to clinical diagnostics

• Cytokines and growth factors array

• Biochip array technology for cardiac research

• Drugs of abuse test wins FDA clearance

• Quality control for tumour markers

• Barcodes on packaging for these reagents

• Convenience is key in bile acids assay

• Biochip technology comes to the routine lab